Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease

A synthetic progestin, medroxyprogesterone acetate (MPA), was used in a novel study to determine progestin effects on human purified macrophages and Th1, Th2, Th17, Th22 cells. MPA concentrations were equivalent to those in the serum of women after 6 and 9 months of progestin use. MPA has no effect...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 10; p. 642
Main Authors Piccinni, Marie-Pierre, Lombardelli, Letizia, Logiodice, Federica, Kullolli, Ornela, Maggi, Enrico, Barkley, Marylynn S.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 03.04.2019
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2019.00642

Cover

Abstract A synthetic progestin, medroxyprogesterone acetate (MPA), was used in a novel study to determine progestin effects on human purified macrophages and Th1, Th2, Th17, Th22 cells. MPA concentrations were equivalent to those in the serum of women after 6 and 9 months of progestin use. MPA has no effect on the proliferation of PBMCs and CD4+ T cell clones induced by immobilized anti-CD3 antibodies or by antigen (streptokinase). However, MPA decreases production and mRNA expression of IL-5, IL-13, IFN-γ, T-bet, RORC, and IL-17A but increases production and mRNA expression of IL-22 by CD4+ Th22 cell clones and decreases IL-22 production by Th17 cells. MPA inhibits RORC, but not T-bet and AHR, by Th17 cells but increases AHR mRNA and T-bet expression of established CD4+ Th22 cell clones. This suggests that MPA, at concentrations equivalent to those found in the serum of women after treatment for contraception and hormone replacement therapy, can directly inhibit Th1 responses (against intracellular bacteria and viruses), Th17 (against extracellular bacteria and fungi), Th2 (against parasites) but MPA therapy increases IL-22 produced by Th22 cells mediated by an increased expression of AHR and T-bet controlling inflammation. MPA could be responsible for the tissue damage limited by IL-22 in absence of IL-17A.
AbstractList A synthetic progestin, medroxyprogesterone acetate (MPA), was used in a novel study to determine progestin effects on human purified macrophages and Th1, Th2, Th17, Th22 cells. MPA concentrations were equivalent to those in the serum of women after 6 and 9 months of progestin use. MPA has no effect on the proliferation of PBMCs and CD4+ T cell clones induced by immobilized anti-CD3 antibodies or by antigen (streptokinase). However, MPA decreases production and mRNA expression of IL-5, IL-13, IFN-γ, T-bet, RORC, and IL-17A but increases production and mRNA expression of IL-22 by CD4+ Th22 cell clones and decreases IL-22 production by Th17 cells. MPA inhibits RORC, but not T-bet and AHR, by Th17 cells but increases AHR mRNA and T-bet expression of established CD4+ Th22 cell clones. This suggests that MPA, at concentrations equivalent to those found in the serum of women after treatment for contraception and hormone replacement therapy, can directly inhibit Th1 responses (against intracellular bacteria and viruses), Th17 (against extracellular bacteria and fungi), Th2 (against parasites) but MPA therapy increases IL-22 produced by Th22 cells mediated by an increased expression of AHR and T-bet controlling inflammation. MPA could be responsible for the tissue damage limited by IL-22 in absence of IL-17A.
A synthetic progestin, medroxyprogesterone acetate (MPA), was used in a novel study to determine progestin effects on human purified macrophages and Th1, Th2, Th17, Th22 cells. MPA concentrations were equivalent to those in the serum of women after 6 and 9 months of progestin use. MPA has no effect on the proliferation of PBMCs and CD4+ T cell clones induced by immobilized anti-CD3 antibodies or by antigen (streptokinase). However, MPA decreases production and mRNA expression of IL-5, IL-13, IFN-γ, T-bet, RORC, and IL-17A but increases production and mRNA expression of IL-22 by CD4+ Th22 cell clones and decreases IL-22 production by Th17 cells. MPA inhibits RORC, but not T-bet and AHR, by Th17 cells but increases AHR mRNA and T-bet expression of established CD4+ Th22 cell clones. This suggests that MPA, at concentrations equivalent to those found in the serum of women after treatment for contraception and hormone replacement therapy, can directly inhibit Th1 responses (against intracellular bacteria and viruses), Th17 (against extracellular bacteria and fungi), Th2 (against parasites) but MPA therapy increases IL-22 produced by Th22 cells mediated by an increased expression of AHR and T-bet controlling inflammation. MPA could be responsible for the tissue damage limited by IL-22 in absence of IL-17A.A synthetic progestin, medroxyprogesterone acetate (MPA), was used in a novel study to determine progestin effects on human purified macrophages and Th1, Th2, Th17, Th22 cells. MPA concentrations were equivalent to those in the serum of women after 6 and 9 months of progestin use. MPA has no effect on the proliferation of PBMCs and CD4+ T cell clones induced by immobilized anti-CD3 antibodies or by antigen (streptokinase). However, MPA decreases production and mRNA expression of IL-5, IL-13, IFN-γ, T-bet, RORC, and IL-17A but increases production and mRNA expression of IL-22 by CD4+ Th22 cell clones and decreases IL-22 production by Th17 cells. MPA inhibits RORC, but not T-bet and AHR, by Th17 cells but increases AHR mRNA and T-bet expression of established CD4+ Th22 cell clones. This suggests that MPA, at concentrations equivalent to those found in the serum of women after treatment for contraception and hormone replacement therapy, can directly inhibit Th1 responses (against intracellular bacteria and viruses), Th17 (against extracellular bacteria and fungi), Th2 (against parasites) but MPA therapy increases IL-22 produced by Th22 cells mediated by an increased expression of AHR and T-bet controlling inflammation. MPA could be responsible for the tissue damage limited by IL-22 in absence of IL-17A.
Author Kullolli, Ornela
Maggi, Enrico
Lombardelli, Letizia
Logiodice, Federica
Piccinni, Marie-Pierre
Barkley, Marylynn S.
AuthorAffiliation 2 Immunology Area, IRCCS Bambino Gesù Children's Hospital , Rome , Italy
1 Department of Experimental and Clinical Medicine and Center of Excellence for Research, Transfer and High Education DENOTHE of the University of Florence , Florence , Italy
3 Department of Neurobiology, Physiology and Behavior, University of California, Davis , Davis, CA , United States
AuthorAffiliation_xml – name: 2 Immunology Area, IRCCS Bambino Gesù Children's Hospital , Rome , Italy
– name: 1 Department of Experimental and Clinical Medicine and Center of Excellence for Research, Transfer and High Education DENOTHE of the University of Florence , Florence , Italy
– name: 3 Department of Neurobiology, Physiology and Behavior, University of California, Davis , Davis, CA , United States
Author_xml – sequence: 1
  givenname: Marie-Pierre
  surname: Piccinni
  fullname: Piccinni, Marie-Pierre
– sequence: 2
  givenname: Letizia
  surname: Lombardelli
  fullname: Lombardelli, Letizia
– sequence: 3
  givenname: Federica
  surname: Logiodice
  fullname: Logiodice, Federica
– sequence: 4
  givenname: Ornela
  surname: Kullolli
  fullname: Kullolli, Ornela
– sequence: 5
  givenname: Enrico
  surname: Maggi
  fullname: Maggi, Enrico
– sequence: 6
  givenname: Marylynn S.
  surname: Barkley
  fullname: Barkley, Marylynn S.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31001262$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1vEzEQhleoiJbSOyfkI4cm-Gu9uxekKAUaqQipLeJoOfY4cbW7Dra3av4RPxNvkkKLxB68tmfmeeWZ93Vx1PseiuItwVPG6uaDdV03TCkmzRRjwemL4oQIwSeMUn70ZH9cnMV4h_PHG8ZY-ao4ZgRjQgU9KX59BRP8w3YT_ApigpA10ExDUgnQBegAKkJEt2tyPi7VOVK9QYv-b4BSdA1x4_vxeO8Uml1eoxu36lXr-hX6sXZ6jeZ-aA2aWQs6oZshatgkt3StS1uUfOaNAZcZB7xtVdep5MMWXbg4Sr0pXlrVRjg7_E-L758_3c4vJ1ffvizms6uJ5oKmiaZYNJpBA3VtWCNqy0qKaakpgC2hhlIZQcplTayqBNcNNMLg3CulRK0azk6LxZ5rvLqTm-A6FbbSKyd3Fz6spArJ6RbksmS8tpURmltOGFdGkUrpKpMYM3RkfdyzNsOyA6OhT0G1z6DPI71by5W_l4KXoiIkA94fAMH_HPJ8ZOdy79pW9eCHKCklpOH5PSynvnuq9UfkcdQ5QewTdPAxBrBSuzzl3PQs7VpJsBxtJXe2kqOt5M5WuRD_U_jI_m_Jb0bt0rY
CitedBy_id crossref_primary_10_3390_molecules28114354
crossref_primary_10_1038_s41540_022_00250_9
crossref_primary_10_1089_aid_2019_0228
crossref_primary_10_1136_thoraxjnl_2020_215540
crossref_primary_10_1016_j_jaci_2020_02_027
crossref_primary_10_3389_fmed_2021_708140
crossref_primary_10_3389_fimmu_2022_911546
crossref_primary_10_3389_fcimb_2023_1149679
crossref_primary_10_1016_j_jinf_2024_106133
crossref_primary_10_3389_fendo_2022_840398
crossref_primary_10_1111_imr_13078
crossref_primary_10_1097_HC9_0000000000000269
crossref_primary_10_1128_mbio_03137_22
crossref_primary_10_3390_biom12091299
crossref_primary_10_3389_fimmu_2021_688066
crossref_primary_10_1038_s41392_023_01655_6
crossref_primary_10_1016_j_jaci_2020_11_024
crossref_primary_10_3389_fcell_2020_589752
crossref_primary_10_1016_j_intimp_2020_106877
crossref_primary_10_31450_ukrjnd_2_82__2024_05
crossref_primary_10_3390_children9020233
crossref_primary_10_3390_pharmaceutics15122787
crossref_primary_10_1080_20565623_2025_2459001
crossref_primary_10_3389_fimmu_2024_1437046
crossref_primary_10_1016_j_scitotenv_2023_167495
crossref_primary_10_1111_aji_13405
Cites_doi 10.1097/OLQ.0000000000000975
10.1016/S0959-8049(96)00486-8
10.1084/jem.20092054
10.1159/000331437
10.1210/jcem-44-1-32
10.1002/1097-0142(19880601)61:11<2214::AID-CNCR2820611115>3.0.CO;2-V
10.1016/0167-5699(93)90235-D
10.1093/aje/kwi116
10.1164/ajrccm/148.2.401
10.1002/ijc.20016
10.1053/j.gastro.2011.04.007
10.1210/endo-77-5-897
10.4049/jimmunol.175.11.7348
10.1007/BF01541085
10.1097/01.aids.0000218563.12897.ba
10.1038/nature06880
10.1016/j.bcp.2008.09.037
10.1038/2006
10.1164/ajrccm/137.1.62
10.1111/j.1600-6143.2005.00892.x
10.1128/IAI.01189-12
10.1097/00007890-196803000-00010
10.1159/000237014
10.1016/j.febslet.2005.10.023
10.1038/ni.1767
10.1210/er.2017-00103
10.1038/ni1254
10.1038/bjc.1993.202
10.4049/jimmunol.149.9.3023
10.1128/MCB.25.22.10040-10051.2005
10.1016/0264-410X(95)00104-9
10.1089/1079990041689665
10.1016/0167-5699(94)90021-3
10.1016/j.immuni.2012.08.024
10.1038/nature06881
10.1677/jme.0.0250169
10.1016/S0092-8674(00)80702-3
10.1007/BF02918503
10.1080/0891693031000067287
10.1016/0959-8049(94)90123-6
10.1038/sj.clpt.6100040
10.1016/S0002-9378(00)70325-5
10.1093/humrep/den192
10.1016/S0140-6736(97)04240-2
10.4049/jimmunol.179.10.6952
10.1084/jem.172.6.1861
10.1111/odi.12094
10.1016/S2214–109X(15)00086–8
10.1186/s12948-015-0015-y
10.1084/jem.177.4.1199
10.1046/j.1365-2710.2000.00310.x
10.1007/BF00205489
10.1371/journal.pmed.1001778
10.1007/s00204-014-1261-3
10.1159/000052948
10.1146/annurev.iy.07.040189.001045
10.1128/JVI.77.18.9845-9851.2003
10.1034/j.1600-0897.2002.01104.x
10.1080/gye.15.4.304.311
10.1016/S1472-6483(10)61033-4
10.1016/j.micinf.2013.06.012
10.1016/j.it.2009.06.005
10.1016/S0165-0378(01)00111-5
10.4049/jimmunol.160.5.2343
10.1053/beog.2002.0268
10.1210/en.2012-1850
10.1159/000087904
10.1371/journal.pone.0079819
10.4049/jimmunol.1300567
10.1371/journal
10.1128/JVI.77.8.4558-4565.2003
10.1046/j.0019-2805.2001.01281.x
10.1038/ni.1770
10.7196/SAMJ.2018.v108i8.13160
10.1016/0167-5699(91)90120-I
ContentType Journal Article
Copyright Copyright © 2019 Piccinni, Lombardelli, Logiodice, Kullolli, Maggi and Barkley. 2019 Piccinni, Lombardelli, Logiodice, Kullolli, Maggi and Barkley
Copyright_xml – notice: Copyright © 2019 Piccinni, Lombardelli, Logiodice, Kullolli, Maggi and Barkley. 2019 Piccinni, Lombardelli, Logiodice, Kullolli, Maggi and Barkley
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2019.00642
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_b5348f7d6c4f4134ada17ac7a6833d24
PMC6456711
31001262
10_3389_fimmu_2019_00642
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-c2069c3e9e88d3968f352025c2eef5e8e5ad615b81fa764c9e96d0166aa68a943
IEDL.DBID DOA
ISSN 1664-3224
IngestDate Wed Aug 27 01:31:20 EDT 2025
Thu Aug 21 14:09:00 EDT 2025
Thu Sep 04 17:17:52 EDT 2025
Thu Jan 02 22:59:26 EST 2025
Tue Jul 01 00:39:29 EDT 2025
Thu Apr 24 23:01:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords infection
Th22
medroxyprogesterone acetate
hormone replacement therapy
Th1
Th17
contraception
Th2
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-c2069c3e9e88d3968f352025c2eef5e8e5ad615b81fa764c9e96d0166aa68a943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Detlef Neumann, Hannover Medical School, Germany
This article was submitted to Cytokines and Soluble Mediators in Immunity, a section of the journal Frontiers in Immunology
Reviewed by: Ana Claudia Zenclussen, Universitätsklinikum Magdeburg, Germany; Cristiana Stellato, University of Salerno, Italy; Roberta Bulla, University of Trieste, Italy
OpenAccessLink https://doaj.org/article/b5348f7d6c4f4134ada17ac7a6833d24
PMID 31001262
PQID 2211946153
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_b5348f7d6c4f4134ada17ac7a6833d24
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6456711
proquest_miscellaneous_2211946153
pubmed_primary_31001262
crossref_citationtrail_10_3389_fimmu_2019_00642
crossref_primary_10_3389_fimmu_2019_00642
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-04-03
PublicationDateYYYYMMDD 2019-04-03
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-04-03
  day: 03
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2019
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Gillgrass (B63) 2003; 77
Quintana (B77) 2008; 453
Gronroos (B30) 1984; 17
Turcotte (B60) 1968; 6
Piccinni (B6) 1995; 1
Lombardelli (B16) 2013; 191
Shi (B82) 2007; 179
Egan (B73) 1995; 107
Piccinni (B11) 2001; 52
Chu (B69) 2005; 161
Piccinni (B44) 2014; 20
Rataj (B35) 2015; 89
Brind (B55) 2015; 30
Mostad (B67) 1997; 350
Morrison (B56) 2015; 12
Harrington (B3) 2005; 11
Vermeulen (B34) 2001; 104
McCarthy (B53) 2019
Negishi (B39) 2005; 175
Huijbregts (B32) 2013; 3
Duhen (B4) 2009; 10
Wardlaw (B72) 1988; 137
Burns (B57) 2005; 5
Affandi (B22) 2002; 16
Nene (B68) 2018; 108
York (B65) 1995; 13
Lédée (B43) 2008; 23
Piccinni (B13) 2005; 13
Scambia (B29) 1988; 61
Hulka (B59) 1965; 77
Ortiz (B26) 1977; 44
Basu (B78) 2012; 37
Cohn (B25) 2007; 81
Loose (B18) 2006
Piccinni (B7) 1998; 4
Romagnani (B2) 1991; 12
Downer (B20) 1993; 67
Kaunitz (B21) 1998; 43
Jabara (B70) 1990; 172
Veldhoen (B76) 2008; 453
Kaushic (B62) 2003; 77
Pedroza-Martins (B66) 2006; 20
Hendricks (B64) 1992; 149
Rodríguez-Sosa (B80) 2005; 579
Piccinni (B15) 2015; 13
Mishell (B24) 1996; 41
Cai (B75) 2012; 158
Fung (B19) 1991; 78
Xu (B17) 2013; 15
Tominaga (B27) 1994; 30
Piccinni (B8) 1996; 15
Piccinni (B9) 2002; 47
Kleynhans (B33) 2013; 81
Kleynhans (B31) 2016; 6
Zurawski (B71) 1994; 15
Szabo (B48) 2000; 100
Flavell (B46) 1998; 19
Monteleone (B81) 2011; 141
Bustin (B42) 2000; 25
Mosmann (B1) 1989; 7
Grabowski (B52) 2015; 3
Turcotte (B49) 1971; 3
Hapgood (B54) 2018; 39
Piccinni (B10) 2003; 36
Suthanthiran (B58) 1995; 15
Malmgaard (B61) 2004; 24
Wegmann (B14) 1993; 14
Piccinni (B12) 2005; 89
Bulun (B38) 2000; 182
Manetti (B45) 1993; 177
Baba (B37) 2005; 25
Kos-Kudła (B51) 2001; 15
Sonnenberg (B83) 2010; 207
Trifari (B5) 2009; 10
Kamada (B41) 2001; 52
Esser (B79) 2009; 30
Kos-Kudła (B50) 2000; 25
Stahlberg (B23) 2004; 109
Duarte (B40) 2013; 8
Mantovani (B28) 1997; 33
Lee (B47) 1998; 160
Hernández-Ochoa (B36) 2009; 77
Robinson (B74) 1993; 148
References_xml – volume: 41
  start-page: 381
  year: 1996
  ident: B24
  article-title: Pharmacokinetics of depot medroxyprogesterone acetate contraception
  publication-title: J Reprod Med
– year: 2019
  ident: B53
  article-title: Hormonal contraceptives and the acquisition of sexually transmitted infections: an updated systematic review
  publication-title: Sex Transm Dis.
  doi: 10.1097/OLQ.0000000000000975
– volume: 33
  start-page: 602
  year: 1997
  ident: B28
  article-title: Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by perypheral blood mononuclear cells of cancer patients
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(96)00486-8
– volume: 207
  start-page: 1293
  year: 2010
  ident: B83
  article-title: Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
  publication-title: J Exp Med
  doi: 10.1084/jem.20092054
– volume: 158
  start-page: 252
  year: 2012
  ident: B75
  article-title: Estrogen stimulates Th2 cytokine production and regulates the compartmentalisation of eosinophils during allergen challenge in a mouse model of asthma
  publication-title: Int Arch Allergy Immunol.
  doi: 10.1159/000331437
– volume: 44
  start-page: 32
  year: 1977
  ident: B26
  article-title: Serum medroxyprogesterone acetate. (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-44-1-32
– volume: 61
  start-page: 2214
  year: 1988
  ident: B29
  article-title: Effects of antiestrogen and progestin on immune functions in breast cancer patients
  publication-title: Cancer
  doi: 10.1002/1097-0142(19880601)61:11<2214::AID-CNCR2820611115>3.0.CO;2-V
– volume: 14
  start-page: 353
  year: 1993
  ident: B14
  article-title: Bidirectional cytokine interaction in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?
  publication-title: Immunol Today.
  doi: 10.1016/0167-5699(93)90235-D
– volume: 161
  start-page: 881
  year: 2005
  ident: B69
  article-title: Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwi116
– volume: 148
  start-page: 401
  year: 1993
  ident: B74
  article-title: Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/148.2.401
– volume: 109
  start-page: 721
  year: 2004
  ident: B23
  article-title: Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20016
– volume: 141
  start-page: 237
  year: 2011
  ident: B81
  article-title: Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.04.007
– volume: 77
  start-page: 897
  year: 1965
  ident: B59
  article-title: Effect of synthetic progestational agents on allograft rejection and circulating antibody production
  publication-title: Endocrinology.
  doi: 10.1210/endo-77-5-897
– volume: 175
  start-page: 7348
  year: 2005
  ident: B39
  article-title: Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.175.11.7348
– volume: 15
  start-page: 161
  year: 1995
  ident: B58
  article-title: Immunobiology and immunopharmacology of organ allograft rejection
  publication-title: J Clin Immunol.
  doi: 10.1007/BF01541085
– volume: 20
  start-page: 939
  year: 2006
  ident: B66
  article-title: Interferon-gamma decreases replication of primary R5 HIV-1 isolates in thymocytes
  publication-title: AIDS
  doi: 10.1097/01.aids.0000218563.12897.ba
– volume: 453
  start-page: 65
  year: 2008
  ident: B77
  article-title: Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor
  publication-title: Nature
  doi: 10.1038/nature06880
– volume: 77
  start-page: 547
  year: 2009
  ident: B36
  article-title: The role of the aryl hydrocarbon receptor in the female reproductive system
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2008.09.037
– volume: 4
  start-page: 1020
  year: 1998
  ident: B7
  article-title: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained reccurrent abortions
  publication-title: Nat Med.
  doi: 10.1038/2006
– volume: 137
  start-page: 62
  year: 1988
  ident: B72
  article-title: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hypereactivity
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/137.1.62
– volume: 5
  start-page: 1226
  year: 2005
  ident: B57
  article-title: Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2005.00892.x
– volume: 19
  start-page: 158
  year: 1998
  ident: B46
  article-title: The molecular basis of T cell differentiation
  publication-title: Immunol Res
– volume: 81
  start-page: 1234
  year: 2013
  ident: B33
  article-title: The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis
  publication-title: Infect Immun
  doi: 10.1128/IAI.01189-12
– volume: 6
  start-page: 248
  year: 1968
  ident: B60
  article-title: Immunosuppression with medroxyprogesterone acetate
  publication-title: Transplantation
  doi: 10.1097/00007890-196803000-00010
– volume: 107
  start-page: 321
  year: 1995
  ident: B73
  article-title: Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000237014
– volume: 579
  start-page: 6403
  year: 2005
  ident: B80
  article-title: Over-production of IFN-gamma and IL-12 in AhR-null mice
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2005.10.023
– volume: 10
  start-page: 857
  year: 2009
  ident: B4
  article-title: Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
  publication-title: Nat Immunol.
  doi: 10.1038/ni.1767
– volume: 39
  start-page: 36
  year: 2018
  ident: B54
  article-title: Hormonal contraception and HIV-1 acquisition: biological mechanisms
  publication-title: Endocr Rev.
  doi: 10.1210/er.2017-00103
– volume: 11
  start-page: 1123
  year: 2005
  ident: B3
  article-title: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
  publication-title: Nat Immunol.
  doi: 10.1038/ni1254
– volume: 67
  start-page: 1102
  year: 1993
  ident: B20
  article-title: A double blind placebo controlled trial of medroxyprogesterone acetate. (MPA) in cancer cachexia
  publication-title: Br J Cancer.
  doi: 10.1038/bjc.1993.202
– volume: 149
  start-page: 3023
  year: 1992
  ident: B64
  article-title: IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.149.9.3023
– volume: 25
  start-page: 10040
  year: 2005
  ident: B37
  article-title: Intrinsic function of the aryl hydrocarbon. (dioxin) receptor as a key factor in female reproduction
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.25.22.10040-10051.2005
– volume: 13
  start-page: 1706
  year: 1995
  ident: B65
  article-title: Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implication for immunotherapy of recurrent HSV infection
  publication-title: Vaccine
  doi: 10.1016/0264-410X(95)00104-9
– volume: 24
  start-page: 439
  year: 2004
  ident: B61
  article-title: Induction and regulation of IFNs during viral infections
  publication-title: J Interferon Cytokine Res.
  doi: 10.1089/1079990041689665
– volume: 15
  start-page: 19
  year: 1994
  ident: B71
  article-title: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(94)90021-3
– volume: 37
  start-page: 1061
  year: 2012
  ident: B78
  article-title: Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2012.08.024
– volume: 453
  start-page: 106
  year: 2008
  ident: B76
  article-title: The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
  publication-title: Nature
  doi: 10.1038/nature06881
– volume: 43
  start-page: 73
  year: 1998
  ident: B21
  article-title: Injectable depot medroxyprogesterone acetate contraception: an update for U.S clinicians
  publication-title: Int J Fertil Womens Med.
– volume: 78
  start-page: 1033
  year: 1991
  ident: B19
  article-title: Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate
  publication-title: Obstet Gynecol
– volume: 25
  start-page: 169
  year: 2000
  ident: B42
  article-title: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
  publication-title: J Mol Endocrinol
  doi: 10.1677/jme.0.0250169
– volume: 100
  start-page: 655
  year: 2000
  ident: B48
  article-title: A novel transcription factor, T-bet, directs Th1 lineage commitment
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80702-3
– volume: 3
  start-page: 814
  year: 1971
  ident: B49
  article-title: Allograft prolongation with synthetic progestins
  publication-title: Transplant Proc
– volume: 15
  start-page: 141
  year: 1996
  ident: B8
  article-title: Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines
  publication-title: Immunol Res.
  doi: 10.1007/BF02918503
– volume: 36
  start-page: 1
  year: 2003
  ident: B10
  article-title: Role of immune cells in pregnancy
  publication-title: Autoimmunity
  doi: 10.1080/0891693031000067287
– volume: 30
  start-page: 59
  year: 1994
  ident: B27
  article-title: Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer
  publication-title: Eur J Cancer
  doi: 10.1016/0959-8049(94)90123-6
– volume: 81
  start-page: 222
  year: 2007
  ident: B25
  article-title: The ACTG A5093 Protocol Team. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/sj.clpt.6100040
– volume: 182
  start-page: 767
  year: 2000
  ident: B38
  article-title: Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/S0002-9378(00)70325-5
– volume: 23
  start-page: 2001
  year: 2008
  ident: B43
  article-title: Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor
  publication-title: Hum Reprod
  doi: 10.1093/humrep/den192
– volume: 350
  start-page: 922
  year: 1997
  ident: B67
  article-title: Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(97)04240-2
– volume: 179
  start-page: 6952
  year: 2007
  ident: B82
  article-title: The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.179.10.6952
– volume: 172
  start-page: 1861
  year: 1990
  ident: B70
  article-title: CD40, and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells
  publication-title: J Exp Med.
  doi: 10.1084/jem.172.6.1861
– volume: 20
  start-page: 212
  year: 2014
  ident: B44
  article-title: pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular orallichen planus
  publication-title: Oral Dis.
  doi: 10.1111/odi.12094
– volume: 3
  start-page: e478
  year: 2015
  ident: B52
  article-title: Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214–109X(15)00086–8
– volume: 13
  start-page: 9
  year: 2015
  ident: B15
  article-title: T helper cell mediated-tolerance towards fetal allograft in successful pregnancy
  publication-title: Clin Mol Allergy
  doi: 10.1186/s12948-015-0015-y
– volume: 177
  start-page: 1199
  year: 1993
  ident: B45
  article-title: Natural killer cell stimulatory factor. (interleukin 12 [IL-12]) induces T helper type 1. (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
  publication-title: J Exp Med.
  doi: 10.1084/jem.177.4.1199
– volume: 25
  start-page: 461
  year: 2000
  ident: B50
  article-title: Hormone replacement therapy in postmenopausal asthmatic women
  publication-title: J Clin Pharm Ther
  doi: 10.1046/j.1365-2710.2000.00310.x
– volume: 17
  start-page: 218
  year: 1984
  ident: B30
  article-title: In vitro functions of lymphocytes during high-dose medroxyprogesterone acetate. (MPA) treatment
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/BF00205489
– volume: 12
  start-page: e1001778
  year: 2015
  ident: B56
  article-title: Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1001778
– volume: 89
  start-page: 393
  year: 2015
  ident: B35
  article-title: Progesterone, as well as 17β-estradiol, is important for regulating AHR battery homoeostasis in the rat uterus
  publication-title: Arch Toxicol.
  doi: 10.1007/s00204-014-1261-3
– volume: 52
  start-page: 82
  year: 2001
  ident: B41
  article-title: Transient increase in the levels of T-helper 1 cytokines in postmenopausal woman and the effects of hormone replacement therapy
  publication-title: Ginecol Obstet Invest
  doi: 10.1159/000052948
– volume: 7
  start-page: 145
  year: 1989
  ident: B1
  article-title: TH1 and TH2 cells: different patterns of Lymphokine secretion lead to different functional properties
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.07.040189.001045
– volume: 77
  start-page: 9845
  year: 2003
  ident: B63
  article-title: Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2
  publication-title: J Virol.
  doi: 10.1128/JVI.77.18.9845-9851.2003
– volume: 1
  start-page: 28
  year: 1995
  ident: B6
  article-title: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones
  publication-title: J Immunol
– volume: 47
  start-page: 289
  year: 2002
  ident: B9
  article-title: T-cell cytokines in pregnancy
  publication-title: Am J Reprod Immunol.
  doi: 10.1034/j.1600-0897.2002.01104.x
– volume: 15
  start-page: 304
  year: 2001
  ident: B51
  article-title: Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women
  publication-title: Gynecol Endocrinol
  doi: 10.1080/gye.15.4.304.311
– volume: 13
  start-page: 840
  year: 2005
  ident: B13
  article-title: T cells in normal pregnancy and recurrent pregnancy loss
  publication-title: Reprod Biomed Online
  doi: 10.1016/S1472-6483(10)61033-4
– start-page: 1541
  volume-title: The Pharmacologic Basis of Therapeutics
  year: 2006
  ident: B18
  article-title: Estrogens and progestins
– volume: 15
  start-page: 796
  year: 2013
  ident: B17
  article-title: Progesterone suppresses Th17 cell responses, and enhances the development of regulatory T cells, through thymic stromal lymphopoietin-dependent mechanisms in experimental gonococcal genital tract infection
  publication-title: Microbes Infect
  doi: 10.1016/j.micinf.2013.06.012
– volume: 30
  start-page: 447
  year: 2009
  ident: B79
  article-title: The aryl hydrocarbon receptor in immunity
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2009.06.005
– volume: 52
  start-page: 35
  year: 2001
  ident: B11
  article-title: Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss
  publication-title: J Reprod Immunol.
  doi: 10.1016/S0165-0378(01)00111-5
– volume: 160
  start-page: 2343
  year: 1998
  ident: B47
  article-title: Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-binding protein
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.160.5.2343
– volume: 16
  start-page: 169
  year: 2002
  ident: B22
  article-title: Long-acting progestogens
  publication-title: Best Pract Res Clin Obstet Gynaecol
  doi: 10.1053/beog.2002.0268
– volume: 3
  start-page: 1282
  year: 2013
  ident: B32
  article-title: Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms
  publication-title: Endocrinology
  doi: 10.1210/en.2012-1850
– volume: 89
  start-page: 3
  year: 2005
  ident: B12
  article-title: T cell in pregnancy
  publication-title: Chem Immunol Allergy
  doi: 10.1159/000087904
– volume: 8
  start-page: 1
  year: 2013
  ident: B40
  article-title: Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0079819
– volume: 191
  start-page: 3651
  year: 2013
  ident: B16
  article-title: HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4+ T cells and macrophages
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1300567
– volume: 6
  start-page: e24639
  year: 2016
  ident: B31
  article-title: Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users
  publication-title: PLoS ONE
  doi: 10.1371/journal
– volume: 77
  start-page: 4558
  year: 2003
  ident: B62
  article-title: Progesterone increases susceptibility and decreases immune responses to genital herpes infection
  publication-title: J Virol.
  doi: 10.1128/JVI.77.8.4558-4565.2003
– volume: 30
  start-page: 129
  year: 2015
  ident: B55
  article-title: Risk of HIV Infection in Depot-Medroxyprogesterone Acetate. (DMPA) users: a systematic review and meta-analysis
  publication-title: Issues Law Med
– volume: 104
  start-page: 80
  year: 2001
  ident: B34
  article-title: Medroxyprogesterone acetate enhances in vivo and in vitro antibody production
  publication-title: Immunology
  doi: 10.1046/j.0019-2805.2001.01281.x
– volume: 10
  start-page: 864
  year: 2009
  ident: B5
  article-title: Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells
  publication-title: Nat Immunol
  doi: 10.1038/ni.1770
– volume: 108
  start-page: 629
  year: 2018
  ident: B68
  article-title: Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response
  publication-title: S Afr Med J
  doi: 10.7196/SAMJ.2018.v108i8.13160
– volume: 12
  start-page: 256
  year: 1991
  ident: B2
  article-title: Human TH1 and TH2 subsets: doubt no more
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(91)90120-I
SSID ssj0000493335
Score 2.365435
Snippet A synthetic progestin, medroxyprogesterone acetate (MPA), was used in a novel study to determine progestin effects on human purified macrophages and Th1, Th2,...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 642
SubjectTerms contraception
hormone replacement therapy
Immunology
medroxyprogesterone acetate
Th1
Th17
Th2
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BERIXRHk1QNEicUGqKet9-oCq0FJFSOHQNqI3a727TowaB-IEkX_Ez-zM2g0ERZy4WLLXj13PjOcbzecZQl4zLgvLeZZoDyGKkLZMCs9tworCWueYLQX-4Dz8rAYj8elSXv7-Pbp7gc3W0A77SY3mV29_fl8dgcG_x4gT_O1hWU2nS2RpYelJwNO3yR3wSynq-LAD-19bLMw5l22ucuuFG74plvDfhjv_pk_-4Y9OH5D7HZCk_Vbyu-RWqB-Su21rydUj8msYPDJUkH8ViyHM6kD7DsmFgZ5ErNiEhl5M2AFu9AG1tafwtVgPpCk9awm0sPujsrQ_OKPn1RiRez2mXyaVm9Bj7JBN-5EUQs-XTSTJRL7tii5mcL-W6lU33e1LUMBpTOzTkzY19JiMTj9eHA-SritD4oRKF4lL36nM8ZAFYzzPlCkBwwFycmkIpQwmSOsBJhWGlVYr4bKQKQ_AUlmrjM0Ef0J2aljzHqGKe1EYzTVXGsJEaUxmrPSMmxCYt7JHDm_kkbuuZDl2zrjKIXRBCeZRgjlKMI8S7JE36yu-teU6_nHuBxTx-jwstB0PzObjvLPbvJBcmFJ75UQJ_l5Yb5m2TsNaOPep6JFXNwqSg2FitsXWYbZs8hRr5wnE0z3ytFWY9aMwq8JSBVPQG6q0MZfNkbqaxOLfChCvZuzZ_5j8c3IPX0ckIvEXZGcxX4Z9wFiL4mU0nWv6ISkK
  priority: 102
  providerName: Scholars Portal
Title Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/31001262
https://www.proquest.com/docview/2211946153
https://pubmed.ncbi.nlm.nih.gov/PMC6456711
https://doaj.org/article/b5348f7d6c4f4134ada17ac7a6833d24
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: KQ8
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: GX1
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: M48
  dateStart: 20101001
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixNBEG5kQfAivo0vWvAi7BB7-jnHuOsahHjYB-Y29PRjM4uZiJMI-4_8mVZ1z4ZERC9eGubd01U9_RX1zVeEvGFcNpbzqtAeQhQhbSwaz23BmsZa55iNAn9wnn1W0wvxaS7nO6W-kBOW5YHzwI0byYWJ2isnInxwhfWWaeu0VYZzXyYlUFjGdoKpq4x7Oecy5yUhCqvGsV0uN0jlQn1KJcq9dSjJ9f8JY_5OldxZe07ukbsDaKST3Nn75FboHpDbuYzk9UPycxY8slGQa5WED1ZdoBOHRMJAjxMu7ENPzxfsEBt9SG3nKXwZtgfKkp5msixs_mgtnUxP6Vl7iSi9u6RfFq1b0COshk0niQBCzzZ9IsQkbu01Xa_gfpnW1fXD7SM42zIl8elxTgM9IhcnH86PpsVQgaFwQpXrwpXvVOV4qIIxnlfKRMBrgJJcGUKUwQRpPUCixrBotRKuCpXyACKVBfPYSvDH5KCDd35KqOJeNEZzzZWGkFAaUxkrPeMmBOatHJHxjT1qN8iTY5WMrzWEKWjBOlmwRgvWyYIj8nZ7xbcszfGXc9-jibfnoah22gGuVg-uVv_L1Ubk9Y2D1DAJMbNiu7Da9HWJOnkCsfOIPMkOs30UZlBYqaALes-V9vqyf6RrF0noWwG61Yw9-x-df07u4HAk0hF_QQ7W3zfhJeCpdfMqTR1oP84ZtDNhfgEv_CKu
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medroxyprogesterone+Acetate+Decreases+Th1%2C+Th17%2C+and+Increases+Th22+Responses+via+AHR+Signaling+Which+Could+Affect+Susceptibility+to+Infections+and+Inflammatory+Disease&rft.jtitle=Frontiers+in+immunology&rft.au=Marie-Pierre+Piccinni&rft.au=Letizia+Lombardelli&rft.au=Federica+Logiodice&rft.au=Ornela+Kullolli&rft.date=2019-04-03&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=10&rft_id=info:doi/10.3389%2Ffimmu.2019.00642&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b5348f7d6c4f4134ada17ac7a6833d24
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon